Showing posts with label Brain. Show all posts
Showing posts with label Brain. Show all posts

May 24, 2015

Sunday, May 24, 2015
A team of stem cell researchers, led by Mick Bhatia, director of the McMaster Stem Cell and Cancer Research Institute, have discovered that they can convert adult human blood cells into adult sensory neurons.  In other words, they developed a way to take blood samples and turn them into central nervous system and peripheral nervous system neurons.

The central nervous system (CNS) is the part of the nervous system consisting of the brain and spinal cord.  It integrates information it receives from, and coordinates and influences the activity of, all parts of the body and it contains the majority of the nervous system.

The peripheral nervous system (PNS) is the part of the nervous system that consists of the nerves and ganglia outside of the brain and spinal cord. The main function of the PNS is to connect the CNS to the limbs and organs, essentially serving as a communication relay going back and forth between the brain and the extremities. It is divided into the somatic nervous system and the autonomic nervous system.

It is no secret that understanding pain and how to treat it is complex and limited and, until now, scientists have been unable to obtain a piece of a patient’s neural system to learn more.  According to Bhatia,
"We can actually take a patient's blood sample, as routinely performed in a doctor's office, and with it we can produce one million sensory neurons, that make up the peripheral nerves in short order with this new approach. We can also make central nervous system cells, as the blood to neural conversion technology we developed creates neural stem cells during the process of conversion."
In addition, the researchers tested their process using both fresh blood and cryopreserved blood. “Since blood samples are taken and frozen with many clinical trials, this allows them […] to go back and explore questions around pain or neuropathy to run tests on neurons created from blood samples of patients taken in past clinical trials where responses and outcomes have already been recorded."

Consequently, this new perspective will allow researchers to study neurological diseases and improve treatments. It could mean blood tests might one day predict prognoses of certain diseases long before symptoms arise.  This could also mean the discovery of new medications that more effectively treat pain.  In other words, there may come a day when there is no more need for opioids to merely numb pain, which in turn reduces drug dependency.
"You don't want to feel sleepy or unaware, you just want your pain to go away. But, up until now, no one's had the ability and required technology to actually test different drugs to find something that targets the peripheral nervous system and not the central nervous system in a patient specific, or personalized manner."
Therefore, this research not only leads to a better understanding of neurological diseases, but also leads us to more effective, and less harmful, individualized treatment as well as the ability to prevent or delay the onset of neurological problems.

Blood to feeling: Scientists turn adult human blood cells into neurons

© www.mentalhealthblog.com

April 27, 2011

Wednesday, April 27, 2011
Research at Washington University School of Medicine in St. Louis has uncovered data suggesting that cholesterol-lowering drugs, known as statins, may help clot-busting drugs treat strokes.

Already, statins are well-known for lowering cholesterol, however they have also been recognized for producing other beneficial effects, such as maintaining the health of cells that line our blood vessel walls and increasing our production of nitric oxide, which dilates our blood vessels.

Researchers studied 31 patients that suffered an ischemic stroke, in which a clot blocks blood flow to part of the brain. It was observed that 12 of the 31 subjects already prescribed statins to control cholesterol, experienced more rapid and complete return of blood flow to the blocked areas of the brain.
"We've known that patients on statins have better stroke outcomes, but the data in this study suggest a new reason why: Statins may help improve blood flow to brain regions at risk of dying during ischemic stroke," says senior author Jin-Moo Lee, MD, PhD, director of the cerebrovascular disease section in the Department of Neurology. "If that turns out to be the case, we may want to consider adding statins to the clot-busting drugs we normally give to acute stroke patients."
To study this possibility, patients experiencing an ischemic stroke were treated with a clot-busting drug and followed up with an MRI. This scan was performed during treatment and again three hours later to assess the effectiveness of the clot-busting drug to restore blood flow to the blocked areas.
"To our knowledge, this is the first time someone has looked at the effects of statins on restoration of blood flow using brain tissue-based measurements instead of looking at the opening of blood vessels," says lead author Andria Ford, MD, assistant professor of neurology. "It's harder to do, but we feel it gives us more accurate measurements."
In only a short 3 hour window, twelve of the patients that were already being treated with statins averaged about 50% restored blood flow to affected areas of the brain, whereas the remaining 19 patients that were not already being treated with statins only averaged roughly 13% restored blood flow.

In addition, physicians tested these patients using the National Institutes of Health Stroke Scale, which evaluates speech, movement, attention and sensation, upon arrival at the hospital and at one month following their stroke. These results also demonstrated that patients treated with statins showed more improvement in their scores when assessed a month after their stroke occurred.

Although results appear promising, researchers have not yet determined whether regular doses of statins or merely treatment of stroke with statins produces such results. Further investigation may prove to have a positive impact on society’s number one disabler.

Cholesterol Drugs May Improve Blood Flow After Stroke

© www.mentalhealthblog.com

March 27, 2011

Sunday, March 27, 2011

According to researchers at Temple University's School of Medicine, the popular asthma drug, Zileuton, has shown potential in treating Alzheimer’s disease. This medication works by reducing the amount of amyloid beta that develops and accumulates in the aging brain. Amyloid beta is a peptide that has been known to be involved in the development of Alzheimer's disease.
“In previous studies, the Temple researchers discovered that 5-lipoxygenase, an enzyme long known to exist in the brain, controls the activation state of gamma secretase, another enzyme that is necessary and responsible for the final production of amyloid beta. When produced in excess, amyloid beta causes neuronal death and forms plaques in the brain. The amount of these amyloid plaques in the brain is used as a measurement of the severity of Alzheimer's.”
“Zileuton (trade name ZYFLO) is an orally active inhibitor of 5-lipoxygenase, and thus inhibits leukotrienes (LTB4, LTC4, LTD4, and LTE4) formation.“

Domenico Praticò and fellow researchers tested the effects of this drug on genetically engineered mice with Alzheimer's disease. Results showed that amyloid production and build-up in the brain was reduced by 50% by treating the mice with Zileuton.

Researchers are already aware of substances that can block gamma secretase’s production of amyloid, however completely eliminating a vital function may result in other health problems, such as developing cancer. “Unlike classical gamma secretase inhibitors, Zileuton only modulates the protein expression levels, which keeps some of its vital functions in tact while blocking many of its bad effects, which in this case is the development of the amyloid plaques.”

Fortunately, if clinic trials effectively demonstrate Zileuton’s ability to treat Alzheimer’s disease, the medication could be readily available to patients as it is already FDA-approved and on the market.

In addition, further research may uncover treatments for other untreatable diseases resulting from amyloid plaques accumulating in the brain, such as cerebral amyloid angiopathy, a neurological condition that occurs when amyloid proteins build up on the walls of the arteries in the brain, which increases the risk of hemorrhagic stroke and dementia.

Asthma Drug Could Help Control or Treat Alzheimer's Disease
Zileuton
Cerebral amyloid angiopathy

© www.mentalhealthblog.com

December 17, 2010

Friday, December 17, 2010
It is common knowledge that sleep is an important part of healthy living, but just how important is it? We already know that sleep helps to strengthen our memories and store them in some sort of order so that they may be retrieved as needed at a later date.

Recently, the journal, Current Directions in Psychological Science, has published findings that explain how sleep is also important for the reorganization of memories. According to Jessica D. Payne of the University of Notre Dame, who co-wrote the article with Elizabeth A. Kensinger of Boston College, our brain extracts the emotional details from our memories during our slumber, while keeping the most relevant information in tact so that it may reconfigure those memories and use them to create new and creative ideas.
Payne and Kensinger study what happens to memories during sleep, and they have found that a person tends to hang on to the most emotional part of a memory. For example, if someone is shown a scene with an emotional object, such as a wrecked car, in the foreground, they're more likely to remember the emotional object than, say, the palm trees in the background -- particularly if they're tested after a night of sleep. They have also measured brain activity during sleep and found that regions of the brain involved with emotion and memory consolidation are active.
The table below displays our suggested amount of sleep that is needed at various stages in life:


So, the sleeping brain is actually quite busy. We may not realize how beneficial sleep can be for our brains. Payne says: “People who say they'll sleep when they're dead are sacrificing their ability to have good thoughts now […] we can get away with less sleep, but it has a profound effect on our cognitive abilities”.

Sweet dreams.

Sleep Makes Your Memories Stronger, and Helps With Creativity
Sleep

© www.mentalhealthblog.com

August 8, 2010

Sunday, August 08, 2010
Researchers in Toronto, Canada have developed an experimental brain surgery that may delay the progression of Alzheimer’s disease. Six subjects with Alzheimer’s disease and an average age of 61 experienced this surgery called deep brain stimulation. The subjects continued to take their Alzheimer’s medication throughout the study.

Scientists implanted “electrodes in the brain's hippocampus, which plays a role in long-term memory. The electrical conductor acts as a pacemaker-like device in the head just beneath the skin. It is connected to a battery pack in the chest.”

Consequently, the mini-mental state exam, a cognitive test, revealed that half of the participants experienced a slow-down in the degenerative effects Alzheimer’s disease has on the brain, while the other half continued to decline in a manner typical of the disease’s progression.

While this new research has produced some promising results, deep brain stimulation is not a novel idea since it has been around for decades. For instance, Dr. Andres Lozano, a neurosurgeon at Toronto's University Health Network, experimented with its effects on Parkinson’s disease without success, unfortunately.

Although not all subjects experienced positive outcomes with this surgery, 64 year old, former city counselor from Brampton, Ontario, Robert Linton, recalled vivid memories of a day he spent fishing.
"I'm with my son," Linton recalled to reporters at Toronto Western Hospital. "I could see that muskie coming right at me as I was sitting in the chair, in Technicolor". "That's the power of touching a spot in your brain. I'm sold on it."
Currently, Lozano and his research team are recruiting roughly 50 people willing to install the stimulator. The plan is to activate half of the stimulators immediately and the other half only six months later all the while participants’ knowledge of its activation will remain unknown in order to truly test the benefits of the device.

Although, the true value of this device is not yet known, the actual retail cost if this treatment became available, would be between $15,000 and $20,000 per patient with a battery life of up to five years.

At the moment, I’m unsure whether I approve of this type of treatment. For one, results are insufficient therefore there is no real proof that the surgery will benefit enough people. Secondly, I am reminded of electroconvulsive therapy and I cannot get the image of Nurse Ratched delivering shock therapy out of my head…

Deep brain stimulation tested for Alzheimer's

© www.mentalhealthblog.com

July 28, 2010

Wednesday, July 28, 2010
Recently, Professor Noam Sobel, electronics engineers Dr. Anton Plotkin and Aharon Weissbrod and research student Lee Sela of the Weizmann Institute's Neurobiology Department, have invented a device that could allow persons with disabilities to navigate wheelchairs or communicate simply by inhaling and exhaling through the nose. In addition, this sniffing technology could be useful in assisting health surgeons or pilots perform certain procedures as their nose could act as a third hand.

How exactly can our breaths achieve such feats? “The new system identifies changes in air pressure inside the nostrils and translates these into electrical signals.” Testing was completed with volunteers and quadriplegics and results proved to be very promising. The subjects were able to manoeuvre a wheelchair or play a computer game with as much ease and precision as with a mouse or joystick.
Sniffing is a precise motor skill that is controlled, in part, by the soft palate […] the soft palate is controlled by several nerves that connect to it directly through the braincase. This close link led Sobel and his scientific team to theorize that the ability to sniff -- that is, to control soft palate movement -- might be preserved even in the most acute cases of paralysis. Functional magnetic resonance imaging (fMRI) lent support to the idea, showing that a number of brain areas contribute to soft palate control. This imaging revealed a significant overlap between soft palate control and the language areas of the brain, hinting to the scientists that the use of sniffing to communicate might be learned intuitively.
From this theory, a device that measures changes in air pressure was created with a sensor that fits into the opening of the nostrils. Furthermore, an alternate version that diverts air into the nostrils was produced for patients on respirators. Interestingly, roughly 75% of those on respirators could control and operate the device.

Still, the most striking is that individuals with locked-in syndrome, a state in which their cognitive functions are intact but their bodies are completely paralyzed so that they are “locked” inside their bodies, were able to communicate effectively with their loved ones on account of this new invention. Finally, these patients were able to share their thoughts and feelings with their families for the first time in a very long time.
“One patient who had been locked in for seven months following a stroke learned to use the device over a period of several days, writing her first message to her family. Another, who had been locked in since a traffic accident 18 years earlier wrote that the new device was much easier to use than one based on blinking. Another ten patients, all quadriplegics, succeeded in operating a computer and writing messages through sniffing.”
Moreover, wheelchair navigation can be done effortlessly with this technology. A certain number of inhales or exhales instruct the chair to navigate in certain directions. Two successive sniffs will make the wheelchair advance forward and two exhales will reverse the chair. One inhale followed by an exhale will steer to the left, while an exhale followed by an inhale steers to the right.

Consequently, the technology has received such acclaim that four of the research subjects are still using the device to communicate. Researchers’ claim that this system is fairly inexpensive to manufacture, not to mention easy for people to learn and operate in comparison to other types of similar technology already in use. Yeda Research and Development Company are currently looking to develop and distribute the technology to the general public, therefore it may not be long until this technology is put to good use.

Invention Enables People With Disabilities Communicate and Steer a Wheelchair by Sniffing

© www.mentalhealthblog.com

May 28, 2010

Friday, May 28, 2010
Previous research has found that mice, which are missing the Hox genes, a group of core developmental genes, groom themselves compulsively to the point of removing their own hair and leaving self-inflicted sores. Additionally, a more recent study has discovered a link between the Hoxb8 gene and behaviors similar to those found in people with obsessive compulsive spectrum disorder (OCD) and that these mice can be cured with a bone marrow transplant.
“It turns out that the Hoxb8 gene in question plays an important role in the development of immune cells known as microglia, which reside in the brain. Studies in which the researchers labeled Hoxb8 cells found that they show up in the brain exclusively in bone marrow-derived microglia. When they transplanted healthy bone marrow from control mice into the mutant animals, normal microglia made it to the animals' brains in about four weeks' time and many of the animals then stopped their incessant grooming, allowing their hair to grow back in, within three months of the procedure.”
Microglia is a type of glial cell that acts as the first and main form of active immune defense in the central nervous system. During the process of blood cellular formation, some hematopoietic stem cells, which are any cells within the bone marrow whose function is to produce blood cells, give rise to microglia. According to Mario Capecchi of Howard Hughes Medical Institute and University of Utah School of Medicine, hox genes are heavily involved in hematopoietic stem cells, which are critical for the proper number and placement of embryonic segment structures, such as legs, antennae, and eyes.

Capecchi explains that “the classic job of microglia, which outnumber neurons in the brain, is to scan the brain for problems […] When they find that something is wrong -- maybe a pathogen has invaded or there has been a stroke -- they change their shape to infiltrate the area and "clean up the mess." Amazingly, microglia can scan the whole brain in only an hour.

These cells maneuver around the brain and make stops at active neuronal synapses monitoring brain activity. From this research, Capecchi believes that microglia may also regulate neural activity and when it is unable to, as in the case of Hoxb8 mutants, pathologies like OCD-like behaviors may result. The exact way in which microglia controls brain activity is not yet known; however these findings suggest that the immune system may have a larger role in mental health disorders. Capecchi states:
"we have provided strong support for the hypothesis that the excessive pathological grooming behavior exhibited by Hoxb8 mutant mice is caused by a defect in microglia. That a behavioral deficit could be corrected by bone marrow transplantation is indeed surprising. The therapeutic implications of our study on amelioration of neurological behavioral deficits in humans have not escaped us."
Capecchi explains that a connection exists between the immune system and disorders such as depression, autism, Alzheimer's, OCD and schizophrenia, but it has never been entirely clear. This study should lead to more exciting discoveries in how microglia can affect neural activity and behavior. Perhaps our vast knowledge of the immune system could lead to more discoveries and treatments for mental illness.

Compulsive Behavior in Mice Cured by Bone Marrow Transplant
Microglia

© www.mentalhealthblog.com

April 18, 2010

Sunday, April 18, 2010
Richard Borgens and his team from the Center for Paralysis Research at the Purdue School of Veterinary Medicine have discovered that chitosan can repair damaged nerve cell membranes. In doing so, the repaired membranes of nerve cells can re-establish the spinal cord's ability to transmit signals to the brain, thus restoring motor abilities.

“Chitosan (pronounced /ˈkaɪtɵsæn/) is a linear polysaccharide composed of randomly distributed β-(1-4)-linked D-glucosamine (deacetylated unit) and N-acetyl-D-glucosamine (acetylated unit).” It is produced commercially by deacetylation of chitin, a derivative of glucose. Chitin can be found in crabs, lobsters, shrimps, insects, squid, octopuses and cell walls of fungi to name a few.

Firstly, the researchers converted chitin to chitosan. They then isolated and compressed a segment of a guinea pig’s spinal cord. Following this, they applied chitosan and a fluorescent dye into the cells through damaged membranes. All of the neurons in the spinal cord tissue remained unstained by the dye under the microscope. While measuring the guinea pig’s brain response, it was noted that signals could not reach the brain because of the damaged spinal cord. “However, 30•min after injecting chitosan into the rodents, the signals miraculously returned to the animals' brains.” Hence, the nerve cells had been successfully repaired.

Borgens and his team also discovered that the levels of LDH leakage from the spinal cord tissue treated with chitosan were lower than those in undamaged spinal cords. “Lactate dehydrogenase catalyzes the interconversion of pyruvate and lactate with concomitant interconversion of NADH and NAD+. It converts pyruvate, the final product of glycolysis to lactate when oxygen is absent or in short supply, and it performs the reverse reaction during the cori cycle in the liver.” Understanding the function of LDH is quite complex, however, in layman’s terms, high levels of LDH are an indication of tissue breakdown or necrosis.

In addition, the researchers uncovered that the sugar repaired any damaged portions of the cell membrane, not only the compressed portion. During their studies, they also found that chitosan could likely be used to repair mitochondrial membranes. “Mitochondria have been implicated in several human diseases, including mitochondrial disorders and cardiac dysfunction, and may play a role in the aging process.” Could further research lead to developing treatments for certain genetic disorder and neurodegenerative diseases?

Chitosan
First Evidence That Chitosan Could Repair Spinal Damage
Lactate dehydrogenase
Mitochondrion

© www.mentalhealthblog.com

March 21, 2010

Sunday, March 21, 2010
It’s no surprise that before the human brain and its particularities can be fully understood that corporations will be utilizing major life-enhancing equipment for their own personal gain. Researchers at Duke University and Emory University suggest in their recent analysis that functional MRI can be used as a cost-effective marketing tool.
“Functional Magnetic Resonance Imaging (fMRI) is a type of specialized MRI scan. It measures the hemodynamic response (change in blood flow) related to neural activity in the brain or spinal cord of humans or other animals. It is one of the most recently developed forms of neuroimaging. Since the early 1990s, fMRI has come to dominate the brain mapping field due to its relatively low invasiveness, absence of radiation exposure, and relatively wide availability.”

“So-called "neuromarketing" takes the tools of modern brain science, like the functional MRI, and applies them to the somewhat abstract likes and dislikes of customer decision-making. Though this raises the specter of marketers being able to read people's minds (more than they already do), neuromarketing may prove to be an affordable way for marketers to gather information that was previously unobtainable, or that consumers themselves may not even be fully aware of, says Dan Ariely, the James B. Duke professor of psychology and behavioral economics at Duke.”
In essence, the results from the study of brain scans that boost sales for materialistic items like food and cars is viewed as more valuable than the understanding of mental illness. Evidently, many people view this as a misuse or abuse of valuable medical resources in an attempt at controlling society.

There is no need to describe the obvious ethical issues involved in such techniques that allows marketers to peek into the brains of their consumers, but considerations must be given to consumers’ awareness, consent, and understanding of what could be an invasion of privacy. Moreover, how could toy companies employ such a method?

Despite these concerns, this type of marketing technique could actually do some good by reducing the number of advertisements that use shock tactics and sexual imagery as main selling points for their products. In addition, companies might actually improve their products to meet consumer expectancy.

Obviously the main function of this technique is not to increase scientific knowledge, but a by-product of such marketing tools could lead to a better understanding of how the human brain creates, stores, recalls and relates information. Furthermore, side-effects of such studies could also mean healthier advertising, for instance, reducing negative influences that lead to over-consumption.

If this is where advertising is going, we can only hope that companies will employ professionals to interpret the brain scans as images must be carefully interpreted by individuals with extensive training since misinterpretation could have serious consequences, even for companies promoting their products.

“Neuromarketing may never be cheap enough to replace focus groups and other methods used to assess existing products and advertising, but it could have real promise in gauging the conscious and unconscious reactions of consumers in the design phase of such varied products as "food, entertainment, buildings and political candidates," Ariely says.”

Nonetheless, there could never be enough benefits from this type of marketing to hold more value than the fMRI’s initial intent, in my opinion.

Brain Scans Could Be Marketing Tool of the Future
Functional magnetic resonance imaging
What is ‘neuromarketing’? A discussion and agenda for future research

© www.mentalhealthblog.com

January 23, 2010

Saturday, January 23, 2010
The term concussion originates from the Latin concutera, which means to shake violently or the Latin concussus, which refers to the action of striking together. It is the most common type of traumatic brain injury. The terms mild brain injury, mild traumatic brain injury (MTBI), mild head injury (MHI), and minor head trauma and concussion are often used interchangeably.


The American Academy of Neurology Guidelines ranks the severity of a concussion into 3 grades:

Grade I - Confusion, symptoms last < 15 minutes, no loss of consciousness

Grade II - Symptoms last > 15 minutes, no loss of consciousness

Grade III - Loss of consciousness

Concussion Symptoms:
  • Headache
  • Dizziness
  • Vomiting
  • Nausea
  • Lack of motor coordination
  • Difficulty balancing
  • Light sensitivity
  • Seeing bright lights
  • Blurred vision
  • Double vision
  • Tinnitus
  • Convulsions
  • Confusion
  • Disorientation
  • Difficulty focusing attention
  • Loss of consciousness
  • Post-traumatic amnesia
  • Confusion
  • Slurred or incoherent speech
  • Changes in sleeping patterns
  • Difficulty with reasoning, concentrating, and performing everyday activities
  • Crankiness
  • Loss of interest in favorite activities or items
  • Tearfulness
  • Displays of emotion that are inappropriate to the situation
**Common symptoms in children include restlessness, lethargy, and irritability.

Typically symptoms will go away without treatment. Roughly 1% of treated concussions require surgery for a brain injury. Most often plenty of rest is prescribed with a gradual return to normal activities at a pace that does not cause symptoms to worsen.

Medications may be prescribed to treat symptoms associated with the concussion, such as sleep problems and depression. Analgesics such as ibuprofen can be taken for headaches that frequently occur after a concussion, but acetaminophen is preferred to minimize the risk for complications, such as intracranial hemorrhage. Individuals are advised not to drink alcohol or take drugs that have not been approved by a doctor as they may interfere with the healing process.

Observation to monitor for worsening condition is an important part of treatment. Unconsciousness or altered mental status, convulsions, severe, persistent headache, extremity weakness, vomiting, or new bleeding or deafness in either or both ears suggests that another visit to the doctor is needed. No conclusive evidence suggests that it is necessary to wake a patient up every few hours or not.

Symptoms usually go away entirely within three weeks, though they may persist, or complications may occur. Although the mortality rate is almost zero, repeated concussions can cause cumulative brain damage such as dementia pugilistica or severe complications such as second-impact syndrome.

Certain factors may lengthen recovery time, such as longer periods of amnesia or loss of consciousness, substance abuse, clinical depression, poor health or additional injuries sustained and life stress. For unknown reasons, having had one concussion significantly increases a person's risk of having another. Having previously sustained a concussion has been found to be a strong factor increasing the likelihood of a concussion in the future. The prognosis is likely to differ between adults and children; however little research has been done on concussion in the pediatric population. Concern exists that severe concussions could interfere with brain development in children.

A 2009 study published in Brain found that individuals with a history of concussions might demonstrate a decline in both physical and mental performance for longer than 30 years. Compared to their peers with no history of brain trauma, victims of concussion exhibited the following effects:

    • A decrease in episodic memory (times, places, associated emotions, and other contextual knowledge)
    • A decrease in response inhibition
    • Delayed P3a/P3b waves recorded via EEG
    • An increase in the cortical silence period
    • Reduced muscle speed otherwise known as bradykinesia (slow movement)
In recent news, Canadian researchers suggest that the term concussion is scraped from medical terminology as doctors and parents quite often underestimate the severity of these types of injuries.

“Carol DeMatteo, an occupational therapist and associate clinical professor in the School of Rehabilitation Science at McMaster University in Hamilton, Ont., says children diagnosed with concussions are treated differently from kids with other mild brain injuries.” These children are often sent home from the hospital and returned to school much sooner than those treated for mild brain injuries.

The term mild brain injury takes on a more negative connotation that concussion, which tends to suggests that the prognosis is obviously good. Concussion should not be taken as lightly as evidence suggests people who have experience multiple concussions risk neurological damage or even Alzheimer's disease and other dementias.

Natasha Richardson’s tragic death is a perfect example of what might happen when brain injuries are not taken seriously enough. On 16 March 2009, Richardson sustained a head injury when she fell while taking a skiing lesson at the Mont Tremblant Resort in Quebec. The injury was followed by a lucid interval, when she appeared to be fine as she was able to talk and act normally. Paramedics were told they were not needed. She returned to her hotel room and about three hours later was taken to a local hospital in Sainte-Agathe-des-Monts after complaining of a headache. About 7 hours following her fall, she was transferred by ambulance to Hôpital du Sacré-Cœur, in Montreal, in critical condition. The following day she was flown to Lenox Hill Hospital in New York City, where she died on 18 March. An autopsy conducted by the New York City Medical Examiners Office on 19 March revealed the cause of death was an "epidural hematoma due to blunt impact to the head", and her death was ruled an accident. There is a lot of controversy surrounding her death as many believe it could have been prevented with proper medical care.

If the term "mild traumatic brain injury" replaced "concussion", it would help people understand that this type of injury is serious and that it is an injury to the brain, not just the head. It could also save lives and prevent more serious complications later in life.

'Concussion' underplays severity of injury: doctors
Concussion
Natasha Richardson

© www.mentalhealthblog.com

October 11, 2009

Sunday, October 11, 2009
Lead author, Sam Harris, professor of psychiatry at the UCLA Staglin Center for Cognitive Neuroscience, and co-lead author, Jonas Kaplan, research assistant professor at the USC's Brain and Creativity Institute, performed the first neuroimaging study to systematically compare religious faith with ordinary cognition.

The study has demonstrated that our brains respond differently to religious and nonreligious statements, however the information seems to get processed in the same brain regions. In other words, our judgement on the truthfulness of religious statements occurs within the same brain regions, despite whether we believe or not.

The study included 30 adult subjects, in which half were devout Christians and the remaining half were non-believers. All subjects judged the reliability of religious and non-religious statements while undergoing three functional MRI (fMRI) scans. The statements used were certain to generate agreement in both groups.

The ventromedial prefrontal cortex (VMPFC), a brain region said to be involved with reward and judgements of self-relevance, showed increased activity when evaluating statements related to beliefs in God, the Virgin Birth and ordinary facts.

However, religious thought appears to be more associated with areas of the ventromedial prefrontal cortex that govern emotion, self-representation and cognitive conflict in both believers and nonbelievers.

Conversely, our thoughts about ordinary facts seem more reliant upon areas associated with memory retrieval. This study helps to illustrate that no matter how much or how often religion is forced upon us, our brains still believe that religion is not based on factual knowledge.

Interestingly, “activity in the brain's anterior cingulate cortex, an area associated with cognitive conflict and uncertainty, suggested that both believers and nonbelievers experienced greater uncertainty when evaluating religious statements.”

This research suggests that one day it may be possible to distinguish religious belief versus disbelief via neuroimaging techniques. “These results may have many areas of application — ranging from the neuropsychology of religion, to the use of 'belief-detection' as a surrogate for 'lie-detection,' to understanding how the practice of science itself, and truth-claims generally, emerge from the biology of the human brain." In addition, this type of research could shed new light on the study of cult behaviours.

Where Religious Belief And Disbelief Meet

© www.mentalhealthblog.com

Popular Posts

Dentalget.com is dental equipment supplier, we provide high quality dental instruments, dental handpiece at a discount price. Free shipping worldwide.

Categories

9/11 AADD Abortion Academic Success Acetylcholine ADD Adderall Addiction ADHD Adult Attention Deficit Disorder Adultery Advertising Aggression Aging Agreeableness AIDS Air Pressure Alcohol Alcohol Abuse Alcohol Dependence Alcoholism alpha-CaM kinase II Altitude Alzheimer's Amphetamine Amygdala Amyloid Amyloid Deposition Anesthesia Anger Anterior Cingulate Cortex Anterograde Amnesia Anti-Depressants Anti-Psychotic Anticholinergic Anticonvulsant Antiepileptic Antioxidants Anxiety Anxious-Avoidant Anxious-Preoccupied Apolipoprotein E Army Aromatherapy Asperger Syndrome Assessment Associative Learning Asthma Attachment Theory Attention Attention Deficit Disorder Attention Deficit Hyperactivity Disorder Autism Autism Spectrum Disorder Autonomic Nervous System Average Sleep Requirements B-type Natriuretic Peptide Babies Balance Behavioral Problems Behaviour Behavioural Impairment Behavioural Therapy Benadryl Bipolar Disorder Blood Clot Blood Pressure Blue Light Blue Light Goggles Body Mass Index Bone Marrow Brain Brain Development Brain Imaging Brain Injury Brain Stem Brain Surgery Breast Cancer Buddhism bullying Bupropion Business C-reactive Protein Calories CAMH Canada Canadian Charter of Rights and Freedoms Cancer Carbohydrates Cardiovascular Disease Care Facilities Caregiver cars Cdk5 Cell Phone Central Nervous System Centre for Addiction and Mental Health Cerebellum Cerebral Amyloid Angiopathy Cerebral Cortex Cerebrospinal Fluid Cerebrovascular Accident Cerebrovascular Insult Chat Rooms Chewing Childhood Disabilities Childhood Disintegrative Disorder Childhood Emotional Neglect Children Chitin Chitosan Cholesterol Choline Chromosome Chronic Pain Syndrome Chronic Stress Circadian Rhythm Cirrhosis Citalopram Classical Conditioning Climate Change Clot-Busting Drug Co-morbidity Cocaine Cognition Cognitive Development Cognitive Impairment Colloquially Brain Attack Coma Communication Device Communication Technology Concentration Concerta Concussion Conflict Confusion Conscientiousness Control Group Coordination Correlation Cortisol Counselling Couples CPAP Crack CRASH-2 CRASH-3 Creativity Criminal Code Cyberbullying Cyberpsychology Cyklokapron Daytrana Death Death Toll Decision-Making Declarative Memory Deep Brain Stimulation Delusion Dementia Dentures Depression Destrostat Deviant Behaviour Dexedrine Dextromethorphan Diabetes Diet Dietary Supplements Diphenhydramine Disability discrimination Dismissive-Avoidant Disorganized Attachment Disorganized Speech Disorientation Dizziness Docosahexaenoic Acid (DHA) Double-Blind Dream Drinking Drowsiness Drug Abuse Drug Dependence Drug Use Drugs DSM DSM-5 Dual Diagnosis Early Onset Alzheimer's Economic Crisis Ecstasy Effexor Ego Eicosapentaenoic Acid (EPA) Elderly Electrical Stimulation Electroconvulsive Therapy Electrodes Email Embitterment Embolic Emotion Emotional Neglect Emotional Problems Emotional Well-Being Employee Enrivonment Enzyme Epilepsy Estrogen Ethics Evolution Experimental Group Extracellular Signal-Regulated Kinase (ERK) Extroversion Facebook Facebook Fan Page Facebook Friends Family Family Therapy Fast Food Father Father Absenteeism Fatherhood FDA Fear Fearful-Avoidant FeelingBetterNow Fetus Fibrin Fish Oil fluoxetine fMRI Focalin Focus Food Fraud Friday Gamma Secretase Genetic Disorders Genetics Ginkgo Biloba Glucose Glutamate Receptor God Gout Guest Blogger Hair Pulling Haiti Hallucination Hallucinogenic Halo Effect Harm-Reduction Headache Healthy Eating Hearing Heart Attack Heart Disease Hematopoietic Stem Cells Hepatitis Hepatitis C Herbal Supplements Hereditary Angioedema Heredity Heroin High Blood Pressure Hippocampus Hockey Homelessness Hormone Housing Hox Genes Hoxb8 Cells Human Rights Hydromorphone Hyper-social Networker Hyperactivity Hypothalamus Illness Impulse Control Impulsivity Inattentiveness Infant Infidelity Inflammation Insecure Attachment Insomnia Instant Messaging Insulin Intellectual Development Intellectual Disability Internet Intracranial Bleeding Introversion Introvert Ischemic Stroke KASPAR Ketamine Ketogenic Kleptomania Laptop Latent Inhibition Learning Learning Disability Leukotrienes Limbic System Lithium Liver Locked-In Syndrome Long Term Memory Long-Term Potentiation Longevity Lupus Lysteda Maestro Rechargeable System Major Depression Mania MAOI Marriage MDMA Medication Meditation Melatonin Memory Memory Loss Memory Task Men Mental Health Mental Health Forum Mental Heath Mental Illness Metadate Metyrapone Mice Microglia Mild Cognitive Impairment (MCI) Mild Traumatic Brain Injury Military Mind-Body Mindless Eating Mitochondria MOHLTC Mood Disorder Morphine Mortality Rates MRI MS-275 Multiple Sclerosis Muscle Weakness music therapy Narcissism Natasha Richardson National Sleep Foundation Natural Disaster Nature/Nurture Nausea Necrosis Neglect Nerve Neuro-imaging Neurobiology Neurodegeneration Neurodegenrative Diseases Neurodevelopment Disorders Neurogenesis Neurological Disease Neuromarketing Neuron Neuropathy Neuroticism Neurotransmitter News Nintendo Wii Non-REM Sleep Nose Nurse Ratched Nutrition Obesity Obessive Compulsive Spectrum Disorder (OCD) Offspring Olfactory Gland OM3 Emotional Balance Omega 3 Ontario Ontario Review Board Ontario Works Opioid Oral Health Organic Ottawa Over-activity Over-Medication Ovulation Oxidative Cell Oxygen Oxytocin p35 Pacemaker Pain Pain Killer Pain Management Pancreatic Polypeptide Pancreatitis Paralysis Paranoia Paraskevidekatriaphobia Parenthood Parents Parkinson's Paroxetine Paxil PDD-NOS perception Perfume Peripheral Nervous System Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Pathway personality traits Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) PET Scan Pharmacology Phobias Physical Health Physiological Plasmin Plasminogen Plasticity Platelet-Activating Factor Politics Post-Concussion Assessment and Cognitive Test (ImPACT) Potassium Ion Channel Poverty Pregnancy Pressure Procedural Memory Promiscuity Prozac PsychBoard.com Psychiatric Ward Psychological Psychological Inventories Psychologist Psychology Psychology Forum Psychology of Eating Psychosis PTED PTSD Public Health Pyromania Quadriplegic Rehab Relationships Reliability Religion REM Research Retigabine Retrograde Amnesia Rett Syndrome Risperdal Ritalin road rage Robot Robotics Rodent Research Rosiglitazone Samsung Satiety Scales Schizophrenia School Screening Secure Attachment Sedatives Seizure Self-Affirmation Intervention Self-Confidence Self-Esteem Self-Integrity Self-Worth Semantic Memory Senior Seroquel Serotonin Serzone Sex Sex Therapy Sexual Orientation Sexual Satisfaction Shock Therapy Sideline Concussion Assessment Test (SCAT2) Sleep Sleep Apnea Sleep Disorders Sleep Quality Sleep Stages Smartphone Smoking Snacking Sniffing Technology Social Assistance Social Deficits Social Isolation Social Media Social Network Social Rejection Social Skills Social Worker Socialization Societal Change Soft Palate Soldier Somatic Nervous System Spatial Memory Special K Speech Spinal Cord Spinal Cord Injury Spinal Tap Sports Injury SSRI Statin Stem Cell Stimulant Strattera Stress Stress Hormone Stroke Substance Abuse Sugar Suicide Superstition Support Survey Suspicious Tablet Talk Therapy Tamoxifen Tanorexia Tax Payer Technology Television Telomere Temperature Testosterone Texting Therapy Thorazine Threshold Thrombosis Thrombotic Tinnitus Tissue Plasminogen Activator Topographical Disorientation Tranexamic Acid Trauma Treatment Tremors Trial Tribunal Trichotillomania Type-2 Diabetes Vagus Nerve Validity Ventromedial Prefrontal Cortex Video Games Virtual Reality Vision Visual Attention Vitamin B Vitamins Vitiligo Voice Vyvanse Walnuts Weight Loss Welfare Wellbutrin Wernicke–Korsakoff syndrome Wet Brain White Blood Cells Women Work World Health Organization Zileuton Zyban Zyprexa µ-opiate receptors (MOR)